Detalhe da pesquisa
1.
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
BMC Gastroenterol
; 23(1): 222, 2023 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37380950
2.
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Int J Cancer
; 151(12): 2278-2290, 2022 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36054900
3.
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
BMC Gastroenterol
; 22(1): 535, 2022 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36550416
4.
Use of a colonic stent to recover a biliary stent retained by malignant colonic obstruction.
Endoscopy
; 51(9): E257-E258, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31071746
5.
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Cancers (Basel)
; 16(7)2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38611007
6.
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.
Intern Med
; 62(12): 1771-1774, 2023 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36328580
7.
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Liver Cancer
; 12(3): 251-261, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37601981
8.
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 15(22)2023 Nov 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38001666
9.
Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets.
Nat Commun
; 13(1): 6481, 2022 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36309506
10.
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.
Case Rep Gastroenterol
; 16(1): 110-115, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35431768
11.
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
J Gastroenterol
; 57(9): 676-683, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35849192
12.
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
PLoS One
; 17(1): e0262675, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35041693
13.
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 14(2)2022 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35053484
14.
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab.
Medicine (Baltimore)
; 100(42): e27576, 2021 Oct 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34678902
15.
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.
Cancers (Basel)
; 13(16)2021 Aug 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34439111
16.
Newly developed self-expandable Niti-S MD colonic metal stent for malignant colonic obstruction.
World J Gastrointest Surg
; 12(4): 138-148, 2020 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32426093
17.
Endoscopic submucosal dissection for early esophageal neoplasms using the stag beetle knife.
World J Gastroenterol
; 24(15): 1632-1640, 2018 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29686470
18.
Gastric and enteric anisakiasis successfully treated with Gastrografin therapy: A case report.
World J Gastrointest Endosc
; 10(3): 69-73, 2018 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-29564036
19.
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Liver Cancer
; 11(2): 174-177, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35634428